TS-037353 — Expansion of human hematopoietic stem and progenitor (HSPC) cells using Epidermal Growth Factor-Like protein 7 (EGFL7).
Despite recent progress in understanding acute myeloid leukemia (AML) biology and the use of intensive treatments, the long-term overall survival is only 30-40% in younger (<60 years) and <10% in older adult AML patients. This highlights the urgent need for novel therapeutic approaches for a…
